KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBT Margin (2016 - 2025)

Historic EBT Margin for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 4.53%.

  • AbbVie's EBT Margin fell 98900.0% to 4.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.78%, marking a year-over-year decrease of 101800.0%. This contributed to the annual value of 6.6% for FY2024, which is 49100.0% down from last year.
  • Latest data reveals that AbbVie reported EBT Margin of 4.53% as of Q3 2025, which was down 98900.0% from 10.08% recorded in Q2 2025.
  • AbbVie's EBT Margin's 5-year high stood at 36.41% during Q1 2022, with a 5-year trough of 15.02% in Q4 2024.
  • For the 5-year period, AbbVie's EBT Margin averaged around 15.11%, with its median value being 14.26% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 395700bps in 2021, then crashed by -325200bps in 2023.
  • Quarter analysis of 5 years shows AbbVie's EBT Margin stood at 28.69% in 2021, then tumbled by -32bps to 19.61% in 2022, then crashed by -57bps to 8.47% in 2023, then tumbled by -277bps to 15.02% in 2024, then skyrocketed by 130bps to 4.53% in 2025.
  • Its last three reported values are 4.53% in Q3 2025, 10.08% for Q2 2025, and 12.45% during Q1 2025.